REDCARE PHARMACY NV (RDC.DE) Stock Earnings Estimates
Europe - Frankfurt Stock Exchange - FRA:RDC - NL0012044747 - Common Stock
59.95 EUR
-0.7 (-1.15%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.204B 13.59% | 1.799B 49.35% | 2.371B 31.79% | 3.003B 26.68% | 3.594B 19.68% | 4.205B 17.00% | 4.834B 14.96% | 5.585B 15.54% | 5.903B 5.69% | 6.372B 7.95% | 6.725B 5.54% | |
| EBITDA YoY % growth | -13.99M 64.07% | 49.669M 455.03% | 29.778M -40.05% | 64.018M 114.98% | 110.64M 72.83% | 166.79M 50.75% | 212.06M 27.14% | 365.12M 72.18% | N/A | N/A | N/A | |
| EBIT YoY % growth | -53.5M 18.82% | -7.619M 85.76% | -38.439M -404.52% | -11.212M 70.83% | 30.066M 368.16% | 71.066M 136.37% | 209.46M 194.74% | 229.94M 9.78% | 265.93M 15.65% | N/A | N/A | |
| Operating Margin | -4.44% | -0.42% | -1.62% | -0.37% | 0.84% | 1.69% | 4.33% | 4.12% | 4.50% | N/A | N/A | |
| EPS YoY % growth | N/A -46.28% | N/A 74.56% | N/A -91.90% | -0.99 48.65% | 0.20 120.03% | 2.09 955.22% | 7.61 263.76% | 11.78 54.79% | N/A | N/A | N/A |
All data in EUR
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.51 61.44% |
| Revenue Q2Q % growth | 813.44M 20.49% |
| EBITDA Q2Q % growth | 18.938M -57.88% |
| EBIT Q2Q % growth | 1.01M 104.34% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.36 -2.86% | -0.32 | -0.04 | -12.80% |
| Q2 2025 Q2Q % growth | 0.46 319.05% | -0.22 | 0.68 | 313.82% |
| Q1 2025 Q2Q % growth | -0.53 | -0.72 | 0.19 | 26.81% |
| Q4 2024 Q2Q % growth | -1.32 | -0.93 | -0.39 | -42.68% |
| Q3 2024 Q2Q % growth | -0.35 | -0.66 | 0.31 | 47.25% |
| Q2 2024 Q2Q % growth | -0.21 | -0.08 | -0.13 | -159.90% |
| Q4 2021 Q2Q % growth | -2.46 | -1.29 | -1.17 | -90.28% |
| Q3 2021 Q2Q % growth | -0.79 | -0.49 | -0.30 | -59.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 719.234M 25.18% | 730.53M | -11.296M | -1.55% |
| Q2 2025 Q2Q % growth | 709.189M 26.49% | 717.28M | -8.091M | -1.13% |
| Q1 2025 Q2Q % growth | 717.286M 28.04% | 722.84M | -5.554M | -0.77% |
| Q4 2024 Q2Q % growth | 675.137M 27.07% | 690.64M | -15.503M | -2.24% |
| Q3 2024 Q2Q % growth | 574.548M 20.83% | 581.98M | -7.432M | -1.28% |
| Q2 2024 Q2Q % growth | 560.674M 33.53% | 380.37M | 180.304M | 47.40% |
| Q1 2024 Q2Q % growth | 560.216M 50.56% | % | ||
| Q4 2023 Q2Q % growth | 531.318M 62.09% | % | ||
| Q3 2023 Q2Q % growth | 475.5M 67.14% | % | ||
| Q2 2023 Q2Q % growth | 419.9M 46.20% | % | ||
| Q1 2023 Q2Q % growth | 372.1M 22.08% | % | ||
| Q4 2022 Q2Q % growth | 327.8M 13.82% | % | ||
| Q3 2022 Q2Q % growth | 284.5M 19.59% | % | ||
| Q2 2022 Q2Q % growth | 287.2M 14.70% | % | ||
| Q1 2022 Q2Q % growth | 304.8M 7.29% | % | ||
| Q4 2021 Q2Q % growth | 288M 8.80% | 293.18M | -5.18M | -1.77% |
| Q3 2021 Q2Q % growth | 237.9M -0.34% | 248.93M | -11.03M | -4.43% |
| Q2 2021 Q2Q % growth | 250.4M 7.61% | % | ||
| Q1 2021 Q2Q % growth | 284.1M 22.46% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 39.28% | -7.56% | -1.52% |
| Revenue | -1.75% | -2.87% | 0% | -0.43% |